Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer

Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer

Abstract Background A synergistic effect of cyclooxygenase inhibitors (COX‐I) and immune checkpoint inhibitors (ICIs) has been suggested. However, the impact of COX‐I on the efficacy of ICIs is unclear. Here, we aimed to evaluate the relationship between COX‐I use and the efficacy of ICI in patients...

Full description

Bibliographic Details
Main Authors: Osamu Kanai, Takanori Ito, Zentaro Saito, Yuki Yamamoto, Kohei Fujita, Misato Okamura, Masayuki Hashimoto, Koichi Nakatani, Satoru Sawai, Tadashi Mio
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Thoracic Cancer
Subjects:
cyclooxygenase inhibitor
immune checkpoint inhibitor
immunotherapy
lung cancer
oncology
Online Access:https://doi.org/10.1111/1759-7714.13845

Internet

https://doi.org/10.1111/1759-7714.13845

Similar Items